🔎 Trials Near Me

Akèy › Karsinòm selil skuamèz tèt ak kou › North Carolina › Durham

Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan Durham, NC

17 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Ap rekriteFaz 2/3
  • Site#0118, Durham
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06788990

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #12, Durham
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Ap rekriteFaz 3
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06589804

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

Ap rekriteFaz 1/2
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06385080

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Ap rekriteFaz 3
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Laj 60 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04892173

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 1
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT07219212

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Sep 22, 2026 · NCT04671667

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Ap rekriteEtid obsèvasyon
  • UNC- Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Ap rekriteFaz 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Ap rekriteFaz 2/3
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Ap rekriteFaz 2
  • Duke University Medical Center, Durham
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06532279

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Ap rekriteFaz 1
  • Duke Cancer Center /ID# 251975, Durham
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04777994

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

Ap rekriteEtid obsèvasyon
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Apr 28, 2026 · NCT04564989

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Ap rekriteFaz 1
  • Duke Cancer Institute, Durham
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT06778863

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

Ap rekrite
  • Duke University Medical Center, Durham
Laj 18 ak plis · Tout sèks · Mizajou Dec 11, 2025 · NCT05793151

A Study of NX-1607 in Adults With Advanced Malignancies

Ap rekriteFaz 1
  • University of North Carolina, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674

Etid Karsinòm selil skuamèz tèt ak kou nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.